WP
ETON icon

Woodline Partners’s Eton Pharmaceutcials ETON Stock Holding History

Woodline Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Buy
310,879
+140,180
+82% +$4.11M 0.03% 503
2026
Q1 		$4.21M Buy
170,699
+75,212
+79% +$1.32M 0.02% 689
2025
Q4 		$1.61M Buy
+95,487
New +$1.68M 0.01% 797

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Woodline Partners's ETON Position: Q2 2026 in Review

Woodline Partners increased its Eton Pharmaceutcials (ETON) stake by 82% in Q2 2026, buying an estimated $4.11M and bringing the position to 310,879 shares worth $11.3M. The position accounts for 0.03% of the portfolio, ranked #503.

Woodline Partners first reported a position in ETON in Q4 2025 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Woodline Partners held 310,879 shares of Eton Pharmaceutcials worth $11.3M as of Q2 2026.
  • Woodline Partners bought 140,180 Eton Pharmaceutcials shares in Q2 2026, an estimated $4.11M.
  • Eton Pharmaceutcials made up 0.03% of Woodline Partners's portfolio in Q2 2026, its #503 holding.
  • Woodline Partners first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.